Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8956615 | American Journal of Infection Control | 2018 | 6 Pages |
Abstract
Our study shows similar results in overall direct treatment costs, meaning that higher acquisition costs of chlorhexidine-containing dressings did not translate into higher costs. Expenses were primarily outweighed by a lower rate of probable/definite CRBSI and reduced associated costs.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Sebastian M. PhD, Lena M. MD, Jörg Janne MD, Bernd Franke, Oliver A. MD, Maria J.G.T. MD,